Adamu, S. M., Oyewole, O. S., & Kabir, U. F. (2024). Efficacy and safety of combination of poly-ADP-ribose polymerase inhibitor (PARPi) and chemotherapy compared with chemotherapy alone in treatment of recurrent ovarian carcinoma: a systematic review. Nigerian Medical Journal, 65(1), 1–15. https://doi.org/10.60787/nmj.v65i1.447